AbbVie’s Skyrizi Tops Novartis’s Cosentyx In Psoriasis Contest

Head-To-Head Result Will Fuel IL-23 Versus IL-17 Debate

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.